<GlossaryTerm id="CDR0000269133"><TermName>bortezomib</TermName><TermPronunciation>(bor-TEH-zoh-mib)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat adults with multiple myeloma or mantle cell lymphoma. It is also being studied in the treatment of other types of cancer. Bortezomib blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called PS-341 and Velcade.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000710188" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;bortezomib&quot;" language="en" id="_3"/><MediaLink ref="CDR0000710187" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;bortezomib&quot;" language="es" id="_4"/><SpanishTermName>bortezomib</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento del mieloma múltiple o el linfoma de células de manto.  También está en estudio para el tratamiento de otros tipos de cáncer. El bortezomib bloquea la acción de un conjunto de enzimas llamado proteasoma, lo que quizás ayude a impedir la multiplicación de células cancerosas, y las destruya. Es un tipo de inhibidor del proteasoma. También se llama PS-341 y Velcade.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2002-11-24</DateFirstPublished><DateLastModified>2021-09-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000491682" url="/about-cancer/treatment/drugs/bortezomib">Bortezomib</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
